0001213900-22-020268.txt : 20220418 0001213900-22-020268.hdr.sgml : 20220418 20220418083229 ACCESSION NUMBER: 0001213900-22-020268 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220418 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIMI International Medical Inc. CENTRAL INDEX KEY: 0001213660 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 020563302 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34890 FILM NUMBER: 22831081 BUSINESS ADDRESS: STREET 1: NO. 10, HUASHENG ROAD, FLOOR 21 STREET 2: YUZHONG DISTRICT CITY: CHONGQING, P.R. STATE: F4 ZIP: 404100 BUSINESS PHONE: (8604) 1182209211 MAIL ADDRESS: STREET 1: NO. 10, HUASHENG ROAD, FLOOR 21 STREET 2: YUZHONG DISTRICT CITY: CHONGQING, P.R. STATE: F4 ZIP: 404100 FORMER COMPANY: FORMER CONFORMED NAME: BOQI International Medical, Inc. DATE OF NAME CHANGE: 20191216 FORMER COMPANY: FORMER CONFORMED NAME: NF Energy Saving Corp DATE OF NAME CHANGE: 20090825 FORMER COMPANY: FORMER CONFORMED NAME: NF Energy Saving CORP of America DATE OF NAME CHANGE: 20070509 8-K 1 ea158506-8k_bimi.htm CURRENT REPORT
0001213660 false 0001213660 2022-04-18 2022-04-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 18, 2022

 

BIMI International Medical Inc.
(Exact name of registrant as specified in its charter)

 

Delaware   001-34890   02-0563302
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

9th Floor, Building 2, Chongqing Corporation Avenue,
Yuzhong District, Chongqing, P. R. China		  

 

116000

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (8604) 1182209211

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common stock, $0.001 par value   BIMI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

 

On April 18, 2022, the Registrant reported its results of operations for the year ended December 31, 2021. A copy of the press release issued by the Registrant in this connection is furnished herewith as Exhibit 99.1.

 

The information in this Item in this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

  (c) Exhibits

 

Exhibit 99.1   Press Release dated April 18, 2022
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 18, 2022 BIMI International Medical Inc.
   
  By: /s/ Tiewei Song
  Name:  Tiewei Song
  Title: Chief Executive Officer

 

 

2

 

 

 EX-99.1 2 ea158506ex991_bimi.htm PRESS RELEASE DATED APRIL 18, 2022

Exhibit 99.1 

 

BIMI International Medical Inc. Announces Fiscal Year 2021 Financial Results

NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results for the fiscal year ended December 31, 2021.

Revenues for the years ended December 31, 2021 and 2020 were $27,079,795 and $12,844,902, respectively. The increase of $14,234,893 is mainly due to the full year of revenues of the Guanzan Group, which was acquired in March 2020 and acquisitions of the Guoyitang, Qiangsheng, Eurasia and Minkang hospitals in 2021.

For the year ended December 31, 2021, the revenues of the retail pharmacies, wholesale medical devices, wholesale pharmaceuticals and medical services were $316,647, $3,445,107, $16,905,498 and $6,398,379, respectively. For the year ended December 31, 2020, the revenues of the retail pharmacies, wholesale medical devices and wholesale pharmaceuticals were $84,087, $3,059,462 and $ 9,701,353, respectively.

For the year ended December 31, 2021 the Company had a gross profit margin of 17% compared with gross profit margin of 19% for the year ended December 31, 2020. The decrease in the gross profit margin in 2021 was mainly due to the decrease in the wholesale pharmaceuticals segment from 19.1% in 2020 to 2.7% in 2021 caused by a change in the product mix to products with a lower gross profit margin.

The gross profit margin of the retail pharmacies, wholesale medical devices, wholesale pharmaceuticals and medical services segments for the year ended December 31, 2021 were 36.8%, 12.0%, 2.7% and 57.3%, respectively. The gross profit margin of the retail pharmacies, wholesale medical devices, wholesale pharmaceuticals segments for the year ended December 31, 2020 were 16.6%, 18.9% and 19.1%, respectively.

Operating expenses were $12,703,345 for the year ended December 31, 2021 compared to $6,255,098 for the year ended December 31, 2020, an increase of $6,207,182, or 99%. Operating expenses for the year ended December 31, 2021 consisted mainly of salary and employee benefits in the amount of $2,273,313, amortization of the convertible notes in the amount of $1,977,401, selling expenses in the amount of $3,180,252, depreciation and amortization expense of $244,116, audit fees of $543,299, and other professional service fees in the amount of $906,852.

For the year ended December 31, 2021, the Company reported other expense of $26,795,423 relating to the impairment of goodwill compared to other income of $460,552 for the year ended December 31, 2020. For the year ended December 31, 2021, the Guanzan Group incurred an impairment charge of $ 1,923,071. Such impairment charge was recorded after the completion of an earn-out period. Guoyitang incurred an impairment charge of $7,154,393, primarily because the 2021 performance targets set forth in Guoyitang’s acquisition agreement were not met as a result of the pandemic and lockdowns. Zhongshan hospital incurred an impairment charge of $9,134,277, primarily because its 2021 performance targets were not met as a result of the pandemic and lockdowns. The Qiangsheng, Eurasia and Minkang hospitals incurred an impairment charge of $7,916,431, primarily because their 2021 performance targets were not met as a result of the pandemic and lockdowns.

The Company reported a net loss of $34,921,745 for the year ended December 31, 2021, compared to a net loss of $1,877,925 for the year ended December 31, 2020, an increase of $33,043,820.

As of December 31, 2021, the Company had cash of $4,797,849 and negative working capital of $932,493 as compared to cash of $135,309 and working capital of $9,619,274 on December 31, 2020.

“Our newly-acquired businesses were severely impacted by COVID-19 and local lockdowns which caused the significant impairment charges in 2021. We believe the decision for the impairment charges was a responsible action that will benefit our shareholders in the long term. As part of our efforts to improve operations and increase shareholder value, we plan to enhance our smart hospital brand by providing more technical and management support, such as a cloud-based telehealth platform and a medical talent pool program to our existing hospitals, and use our established brand to attract more hospitals that may bring new opportunities and profits to our Company,” said Mr. Tiewei Song, Chief Executive Officer and President of BIMI International Medical Inc.

About BIMI International Medical Inc.

BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and services provider, offering a broad range of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.

Safe Harbor Statement

Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.

IR Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BIMI@dgipl.com

 

 

 

BIMI INTERNATIONAL MEDICAL, INC. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

    December 31     December 31  
    2021     2020  
ASSETS                
CURRENT ASSETS                
Cash   $ 4,797,849     $ 135,309  
Accounts receivable, net     7,005,442       6,686,552  
Advances to suppliers     3,163,836       2,693,325  
Amount due from related parties     622,554       -  
Inventories, net     2,639,883       735,351  
Prepayments and other receivables     2,930,083       14,880,526  
Operating lease-right of use assets     -       53,425  
Total current assets     21,159,647       25,184,488  
                 
NON-CURRENT ASSETS                
Deferred tax assets     207,549       193,211  
Property, plant and equipment, net     3,521,401       910,208  
Intangible assets, net     18,039       -  
Operating lease-right of use assets     4,845,509       -  
Goodwill     8,376,217       6,914,232  
Total non-current assets     16,968,715       8,017,651  
                 
TOTAL ASSETS   $ 38,128,362     $ 33,202,139  
                 
LIABILITIES AND EQUITY                
CURRENT LIABILITIES                
Short-term loans   $ 1,799,394     $ 904,228  
Long-term loans due within one year     369,187       34,201  
Convertible promissory notes, net     5,211,160       3,328,447  
Accounts payable, trade     7,339,210       5,852,050  
Advances from customers     1,943,028       194,086  
Amount due to related parties     730,285       226,514  
Taxes payable     662,777       773,649  
Other payables and accrued liabilities     3,082,917       4,228,976  
Lease liability-current     954,182       23,063  
Total current liabilities     22,092,140       15,565,214  
                 
NON-CURRENT LIABILITIES                
Lease liability-non current     4,161,789       22,457  
Long-term loans - non-current     538,006       720,997  
Total non-current liabilities     4,699,795       743,454  
                 
TOTAL LIABILITIES     26,791,935       16,308,668  
                 
EQUITY                
Common stock, $0.001 par value; 200,000,000 shares authorized; 8,502,222 and 2,650,917 shares issued and outstanding as of December 31, 2021 and 2020, respectively *     8,502       2,651  
Additional paid-in capital     55,220,130       26,355,523  
Statutory reserves     2,263,857       2,263,857  
Accumulated deficit     (47,900,929 )     (12,914,973 )
Accumulated other comprehensive income     1,601,870       1,003,392  
Total BIMI International Medical Inc.’s equity     11,193,430       16,710,450  
                 
NON-CONTROLLING INTERESTS     142,997       183,021  
Total equity     11,336,427       16,893,471  
                 
Total liabilities and equity   $ 38,128,362     $ 33,202,139  

 

  * Retrospectively restated due to five for one reverse stock split, see Note 24

The accompanying notes are an integral part of the consolidated financial statements

 2 

 

 

BIMI INTERNATIONAL MEDICAL, INC. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE GAIN/LOSS

    For the
Years Ended
December 31		  
    2021     2020  
REVENUES     27,079,795       12,844,902  
                 
COST OF REVENUES     22,483,404       10,402,085  
                 
GROSS PROFIT     4,596,391       2,442,817  
                 
OPERATING EXPENSES:                
Sales and marketing     3,180,252       783,134  
General and administrative     9,523,093       5,471,964  
Total operating expenses     12,703,345       6,255,098  
                 
LOSS FROM OPERATIONS     (8,106,954 )     (3,812,281 )
                 
OTHER INCOME (EXPENSE)                
Interest income     3,101       304  
Interest expense     (351,066 )     (84,913 )
Exchange gains     24,967       547,114  
Impairment loss of goodwill     (26,128,171 )     -  
Other expense     (344,254 )     (1,953 )
Total other income (expense), net     (26,795,423 )     460,552  
                 
LOSS BEFORE INCOME TAXES     (34,902,377 )     (3,351,729 )
                 
PROVISION FOR INCOME TAXES     19,368       434,306  
                 
NET LOSS FROM CONTINUING OPERATIONS     (34,921,745 )     (3,786,035 )
                 
DISCONTINUED OPERATIONS                
Income/(loss) from operations of discontinued operations     -       1,908,110  
                 
NET LOSS     (34,921,745 )     (1,877,925 )
Less: net income attributable to non-controlling interest     64,211       119,158  
NET LOSS ATTRIBUTABLE TO BIMI INTERATIONAL MEDICAL INC.   $ (34,985,956 )   $ (1,997,083 )
                 
OTHER COMPREHENSIVE LOSS                
Foreign currency translation adjustment     598,478       (941,957 )
                 
TOTAL COMPREHENSIVE LOSS     (34,323,267 )     (2,819,882 )
Less: comprehensive loss attributable to non-controlling interests     (26,056 )     (17,113 )
COMPREHENSIVE LOSS ATTRIBUTABLE TO BIMI INTERNATIONAL MEDICAL INC.   $ (34,297,211 )   $ (2,802,769 )
                 
WEIGHTED AVERAGE NUMBER OF COMMON SHARES                
Basic and diluted     5,362,927       2,134,562  
                 
LOSS PER SHARE                
Continuing operation-Basic and diluted   $ (6.51 )   $ (1.77 )
Discontinued operation-Basic and diluted   $ -     $ 0.89  
Basic and diluted   $ (6.51 )   $ (0.88 )

 

 3 

 

 

BIMI INTERNATIONAL MEDICAL, INC. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

    For the
Years Ended
December 31,		  
    2021     2020  
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss   $ (34,921,745 )   $ (3,786,035 )
Adjustments to reconcile net loss to cash used in operating activities:                
Depreciation and amortization     244,116       56,041  
Impairment loss of Goodwill     26,128,171       -  
Inventories impairment reserve     93,884       9,294  
Allowance for doubtful accounts     (53,698 )     146,977  
Amortization of discount of convertible promissory notes     554,292       2,091,927  
                 
Change in operating assets and liabilities                
Accounts receivable     685,426       (4,997,548 )
Advances to suppliers     (457,841 )     (1,470,339 )
Inventories     (1,434,531 )     205,580  
Prepayments and other receivables     9,812,297       (1,021,703 )
Operating lease-right of use assets     (976,372 )     (53,425 )
Accounts payable, trade     (453,738 )     4,548,651  
Advances from customers     1,702,762       (1,156,040 )
Operating lease liabilities     915,004       45,520  
Taxes payable     (495,987 )     429,006  
Other payables and accrued liabilities     (2,617,765 )     590,979  
Net cash used in operating activities from continuing operations     (1,275,725 )     (4,361,115 )
Net cash provided by operating activities from discontinued operations     -       843,382  
Net cash used in operating activities     (1,275,725 )     (3,517,733 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Cash received from acquisition of Guanzan Group     -       95,220  
Cash received from acquisition of subsidiaries     189,896       -  
Payment for the acquisition of Qiangsheng, Eurasia and Mingkang Hospitals     (3,136,910 )     -  
Payment for the acquisition of Guoyitang and Zhongshan     -       (9,195,543 )
Deposit for the acquisition of Cogmer     3,065,181       (3,065,181 )
Purchase of property, plant, and equipment     (814,684 )     (258,961 )
Net cash used in investing activities from continuing operations     (696,517 )     (12,424,465 )
Net cash provided by investing activities from discontinued operations     -       11,700,000  
Net cash (used in) investing activities     (696,517 )     (724,465 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from short-term loan     -       65,302  
Proceeds from long-term loan     151,995       534,201  
Net proceeds from issuance of convertible promissory notes     6,500,000       3,457,325  
Repayment of short-term loans     (33,273 )     (216,462 )
Amount financed from (to) related parties     (478,183 )     148,700  
Net cash provided by financing activities from continuing operations     6,140,539       3,989,066  
Net cash provided by financing activities from discontinued operations     -       -  
Net cash provided by investing activities     6,140,539       3,989,066  
                 
EFFECT OF EXCHANGE RATE ON CASH     494,243       386,840  
                 
INCREASE IN CASH     4,662,540       133,708  
CASH AND CASH EQUIVALENTS, beginning of period     135,309       1,601  
CASH AND CASH EQUIVALENTS, end of period   $ 4,797,849     $ 135,309  
                 
SUPPLEMENTAL CASH FLOW INFORMATION:                
Cash paid for income tax   $ 444,633     $ 45,178  
Cash paid for interest expense, net of capitalized interest   $ 163,883     $ 101,417  
                 
NON-CASH TRANSACTIONS OF INVESTING AND FINANCING ACTIVITIES                
Issuance of shares of Common stock for the equity acquisition of Chongqing Guanzan Technology Co., Ltd.   $ 3,818,000     $ 4,537,000  
Issuance of shares of Common stock for equity acquisition of Zhongshan Chaohu Hospital   $ 3,480,000     $ -  
Issuance of shares of Common stock for equity acquisition of Guoyitang Hospital   $ 3,820,000     $ -  
Issuance of shares of Common stock for equity acquisition of Minkang, Qiangsheng and Eurasia hospitals   $ 5,930,619     $ -  
Issuance of shares of Common stock for equity acquisition of Zhuoda   $ 1,498,200       -  
Issuance of shares of Common stock for payment of improvements to offices   $ 696,896       -  
Goodwill recognized from equity acquisition of Zhongshan Chaohu Hospital   $ 10,443,494     $ -  
Goodwill recognized from equity acquisition of Guoyitang Hospital   $ 7,154,393     $ -  
Goodwill recognized from equity acquisition of Minkang, Qiangsheng and Eurasia hospitals   $ 9,067,529     $ -  
Goodwill recognized from equity acquisition of Zhuoda   $ 924,740          
Goodwill recognized from equity acquisition of Guanzan Group   $ 6,914,212     $ 6,914,212  
Outstanding payment for equity acquisition of Zhuoda   $ 4,800,000     $ -  
Outstanding payment for equity acquisition of Guanzan Group   $ -     $ 3,065,181  
Common stock to be issued upon conversion of convertible promissory notes   $ 5,400,000     $ -  

 

 4 

 

 

 

 EX-101.SCH 3 bimi-20220418.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 bimi-20220418_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 bimi-20220418_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Apr. 18, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 18, 2022
Entity File Number 001-34890
Entity Registrant Name BIMI International Medical Inc.
Entity Central Index Key 0001213660
Entity Tax Identification Number 02-0563302
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 9th Floor, Building 2
Entity Address, Address Line Two Chongqing Corporation Avenue
Entity Address, Address Line Three Yuzhong District
Entity Address, City or Town Chongqing
Entity Address, Country CN
Entity Address, Postal Zip Code 116000
City Area Code 8604
Local Phone Number 1182209211
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.001 par value
Trading Symbol BIMI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 ea158506-8k_bimi_htm.xml IDEA: XBRL DOCUMENT 0001213660 2022-04-18 2022-04-18 iso4217:USD shares iso4217:USD shares 0001213660 false 8-K 2022-04-18 BIMI International Medical Inc. DE 001-34890 02-0563302 9th Floor, Building 2 Chongqing Corporation Avenue Yuzhong District Chongqing CN 116000 8604 1182209211 false false false false Common stock, $0.001 par value BIMI NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://bimihc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea158506-8k_bimi.htm bimi-20220418.xsd bimi-20220418_lab.xml bimi-20220418_pre.xml ea158506ex991_bimi.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea158506-8k_bimi.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "ea158506-8k_bimi.htm" ] }, "labelLink": { "local": [ "bimi-20220418_lab.xml" ] }, "presentationLink": { "local": [ "bimi-20220418_pre.xml" ] }, "schema": { "local": [ "bimi-20220418.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "BIMI", "nsuri": "http://bimihc.com/20220418", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea158506-8k_bimi.htm", "contextRef": "From2022-04-18to2022-04-18", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://bimihc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea158506-8k_bimi.htm", "contextRef": "From2022-04-18to2022-04-18", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://bimihc.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001213900-22-020268-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-020268-xbrl.zip M4$L#!!0 ( Y$DE1L\0DE.@, .\+ 1 8FEM:2TR,#(R,#0Q."YX M]PD+VM9='W[JGW4Z M%C@Y?O<6Z%_K/83@@F#J-\$Y]V"'#?D1^(I"W 27F&&!%!='X![1V%CX!:%8 M@#,>1A0KK!UII":H5]P: A!NH7N/F<_%W6UGKCM2*I)-VYY,)A7&QVC"Q9.L M>#S<3K"OD(KE7,V9.MEO.WJ/2&]./GSNU.7'Z2UY"# [C*\?KZ;>#T2ZR+MI M_([JL^N?]'1\Z3M7_?#+U:P7HZ ;1OTZ[EYW';Y_3D"WIC7"(@+X,)MN6 MJ2\K;U*KMY_@K!38G%+"GHK@;J/1L!-O#EU#3@>"YM(UV[@' M2.*YLO:2$CQA4B'FO<#[:DY8!M?MU/D"2@JA'U(HR:$^7L%)[%4"/K:U0^.K M[O-!#HTE#!"*YO ADH-$-G,D<.BXL.;F%"G4.EP;BZ%0S2(L"PFIJX!VVNEU MYHP!"Q6\)!%+[%^SXV0="2PU M+\F]JPT9,8-L('F(>C'=C;-(I9"2&?(S6IQ:/B6W> B2Z6J:FV];DICWS8:&(;L^E M$4]3)\K0;Y;" !-'6L#^%R53--BU9$W!]#_6VC7ZRT5FXV$OYB/;K\Y02Y?+ MA0)L;13+WL;T5>]R+Y$JH9@=S'G0F*!;U0])92K]1::[)+$X@=V2R'E[)+'Q MA2[*0&XFF"5,E]N&+GWM2\,7,FU,EB/GT MOZ(YBO\Y[)O(YM9HV:FF7OX!4$L#!!0 ( Y$DE0\8GCN_PH &R' 5 M 8FEM:2TR,#(R,#0Q.%]L86(N>&ULS9U?4^NX&<;O.]/OH*8W['DP$YF6: DYVS;GFU#IY*X@& ]K_S( M^D62_TC^],-NDZ(7PK.$T?/1].CC"!$:L3BAZ_/1U\7X8C&;ST4Y(3D:!V?(;^>C0]P6@\'I#O-T)CQK_>SZM\'_/\.3N; M3%Y?7X\H>\&OC#]E1Q';#,MPD>-\FU6Y?=Q]+']4^*''_\.)W\X^?K1?1(-GB<4'G<(C+243(76]ST]/1T M4J1J:4NY6_%4[^-DHNU4.8O4I$-?;";23F?R/@) M)6N-O,J@B6NS=X0G++ZD[W-M M1GNR+[X[//\?"E"/=UZ$)5.XL:^::R-6>\ M77;9,Q9Y9B0Z6K.724P2D??Q]#]_D1_'ZF-1=/'O;S,F1@,7JRSG.,IU;D51 MSD>6](EI2RHON/:&>=13P%(QB9CHGI[S<:H.I0I_X&QCW6U95/-U-U"1ZETM$F%0@ZK"!U_78R^+S3H5ZWZ]Z?)(1=' ME2V&0ML-H?E2Y&HI13/9557;3.F:KJ<%4=$60V8]:PF2&@^5?"%V'DL#5RE> M6XI@I+NJ9JLM7<^-Q" JVN;(K.E*@Z3(9U5_(5G$DVNQD;\GZT1V-=*&/.A*HHCRQ=4+K%Z3UY9KP+H:;,-3DVDR8P=4U0G%B,@7@H+5)BCU3\?2O. MY@E/][U@M)2NV0"LFG@8LJ (L7L#(:GD_CE9,\"TOV&QB5T3 QLVF6DK@Z(&M =R4T2@,B0L M="Y?Y*A=#)T&%KBF]PE0RW870Y4X6(Q,AP-)*L*0C/-(4^V610]'+:5K@@"K M)CN&+"AJ[-Y 7I0<%?HP0+FD\2!,*IT?2 R;=D1*48" -)WUX2'4ON&X2K(( MI\K/E=B6=131HG4-"6C7!*4E# H6R!T(C K0W!0AWJ'Y)\%\&#(UI1]@6E;M MN%2R &$QO?6A(O7>0)EM.6\XAWL?6.KL9FZ/V>J^+J + I8>@,5C M;W1)\R3?R^?Q;K:;%>&6 K8EKOB S&DNS/0@> !,F1PH&9(ZI(3>:E_?5:"Y M?! 2+)(I#>/!;#)0Z*>+^\A!=2[!:;'=I,;0!P0/MT. 8I$$&I& M^89I3B/&GUGM<8D9VXK&<#]C,3QBZ8ER"]:@(C3QZ@P)"+(A/@'4&J$?U#,M MB,FY044&2.;@C;J+.!8'*RO_7">43,%C8-6Z):S#;I,KBS @FF!W $.E\H/^ M@&0,NJ4A@7/\AN(>^P?G>"@XQT&#<_P><):O+"!P3MY0W!/_X)P,!>^ ;5'K!IFW5"LU!%AXR+6]]P,@ .;Z1(;Y1*09; MM_R.LY>$1O P&I)[@08P;27'T(:'C]U@'T/5(%G'^0:I'*SW?EFTS$]KTS1I M;VJ4)CQ0FL9Z&QFE]HW%'>X\2;>+O2!B-6P%I:$,#Q>;O3YH5 P2 M0;Y.NDMLY0T0ZW0U(]W=E&.+K<.4XUIB$"#8'+6G'*NK*TKDHZHEJYQ@H&5H M)CNK:(NIJIYK:6%4<]M0JY:+[[?0^/I"RY5ETKM'1N&'"]H25[4-F=,U;J8' M4>N *;/F"QDJ=!ZOW,L5+C)[4UY+<];3FW:JCETG!%'#IIM6MZW3/=3H+SS) MQ=YG;+/9TO+.D.T91$#GJJ8[;>I:MXJ"(*#+F4E#J45-L0L%2@;[X6)-J*_G(_/5XMDSRUG7BV)<[Z)\!2C2$'M T^,_K?Z,=)0'!&[8DF.YJ.UBOUFQ%%@)RZIR!4*'1:#-X X"*2&. 0> MOY%!XR<9A718>;7,&TW?6+JE.>;%''9N:Z$ G5MZ )M-:@Q10+38G0&45&*D MU/XFA:O5*ZJ!EWIG$EA(2.YXBGBG:6.FN%4;$#>=!J%YX^6:(X?QLHKR.)TS M)_)=%\D+^8)S7/H#RPS)74_@[#)MSMRT:0/"J-,@.%>SBI'+U6#-E==E:_A, M#+_6K./I<\-RM&3H:T90_DC09?E:O?K*]2H?GV])B2(YX4*-UFF,N0VC+K'S-Z: MAEOO36DI@X"IUQ[\#I4J ND0#^3<"I9Y_1RO,#+/R0:<2=$?XHJBH>8U2WWZ M((@::-+DJ@AKGG@7@4A&^EY5J;X@/SSL:X@@+6BH7'^_ M@;_U_+:K-(FN4H;AJS -C>-5_-KVC 7\#H* *&B[@I;M*X2H4'ICX#.F3WS[ MG$?[.\XB0N336EG5XM?@,)#%JB6QX=:[^7[ M@I]\&%VN,,>BI\4C%@?Q=IMGLD<5YN KYIU!CF]%#"B <4.B(R(@_ ;8A&Y. M%)&H"/V 5#"J17L\;\L.JQ.2^//^GCP0+N#B MF"=YO8%!@/A6M] I8(;J&:"5?,ZLS +]*C-!12ZV][37-UV+3V*SWB1^K7!& MQ);_ E!+ P04 " .1))4&[8%E5(' "]6 %0 &)I;6DM,C R,C T M,3A?<')E+GAM;,V<77/:.!2&[W=F_X.7O08"='<;FFPGH:'#-&VR@;:[>],1 MM@!-9(F5Y #_?B4;4SXL^>2F)[E("+SZ>)]C9!]+\L7;=.'#).5320Z9)30^T'1B9A-0[QI^N[U:K5I"/I&55(^Z%_ID33R/(2NK_6[++AVMTVN^JUI)JWNV=GG?;?'V_'\8*F MI,F$XQ;31EG*U5)5KG-^?M[./RVE)\KU5/&RC5Z[[,ZN9OLI"^CW>J)97^?= MNY4Q,7G8:YN)O KW7[.4-=U;S4ZWV>NTUCIIE/!S@DIR^D!GD?MKH[=K=Z!THJ8[JK+4MF1?%LIM M-\J.,[V(]4S+U$=K2D)Z.[L.R3?PXHE>V#XGKQY"3>372 M(PF0:0<#:J4;3*KOJ(X56SHV-7 /E$#&753&%=X04)??HPAXC,)XH(S1PC"/13-9#Z[Z@7)!Z/B-C'"\JY2_&( !WM57H@ M^C\PT?M]OA#X-T_NO&]/-W#^>T6 (7C]4D)PXA8Q"O=4,9G84[T"\#\1 \F? M8Y+W.$1G?B,2*/&=%)PCX0,_LH>(>\AT3'C1JZ%]3X>15\BAV%%RTUJ;Z.C_ MH42!P>^)H=A1TM4:BPC0!YE2!QT*CC!^-10[2J):9Q*!^XTPS&S6,DISZ3*'Q+>],"..F0D*,CY50SB@Y:<@<&NN!]:0('XF$KC_0 M30CVB11*&R47#=I#PWVO6$K49LSB^@'D5 L%CI*!A@VB$9^0]2BQSMB,%1.+ M]>"]1:#\4=)/D%VT,(Q$+-52[MUN'LC,?C'#U* MSEIK$QO]P+Z\4Q.Y\LQJ>\50["@Y:XU%;.CYV>=.W2OYQ(IU5W7D3TI \2.F MLF&SV#'8GOPA1WVIA#)'3&NKS6&SOI?:$/XO6]9=95;KH=P1$]R048P;DT7\ MW4T.WW*E(PF4,4I.6VD' ZN+M*+$?Q@?*J!041+5*C,(3&^EFT-92!&\EWNJ M@K)%R3A]IC &8K>,67N'@;V/P:OE4(;98QL(*+\J9FPO!C)-,[&]K^.98?-( MH8A1TL2@/03<8\E9S P3\X_V"E(QPJM95^F@H%&20K\Q!,KWBKJ(4WMIGJ\9 MU-ULYAN)0WHH=92= M[G3B=O%X1IP3%90W2FKH,X7 ]Y.<*.+V#XXWZ51R_U:52B&4,DHB&+"& /J@ M+]6(CR10N"@98*4=Q/'A9ATOB)A3_\J(:B44,DI&&#*'.A;/06/Q_)EC,4IF MZ#.%R+=8GVZ_77=3SN;$O\,M6 "\[P>3>L JQM["?!N2VVVNTKPO0_NB&KU' M"H6.LX4S9 \#=Y8P0Y.B6T,FB(AMZK7;<^?)Y.M+08. L\<3:!IMBN KY?R# MD"LQID1+09,B'0C-$GB+0".!."=98QLUA4O3L?%8\9"5'WE8#"1YR4#)M%7 MGJ.LW>Z+OB"';7H9BX"L!C0'B M!&78+.H:?C6P)Z.Y#,_%'PFAQ!&7X%9:0P,]3@GGUYEF@NK@.',DA()&7&M; M:0T-]$U*U=P.HP4]4 M0$3O-8GYR) X=@LUBC.\2(CRD _IH>Q1-W[ZC2+0OS,+JO:OK?(.C6Q^%UI0 M45\*&@F4M!9J&N]\N_?T@>#I]D '98Z8P%89P]O'E4TYBX='>GO&]!HPUM\XGZY9\W:=_X'4$L#!!0 M ( Y$DE3/4/R-01( .5A 4 96$Q-3@U,#8M.&M?8FEM:2YH=&WE M'.]7XKKRN^?X/^1QW[ZCYPFTY8> +N\ @LNJH(#NNE\\H0T0+4UMBX!__9ND M+10HB JZ]^[>O:N09&8RF9G,3"8Y_M^HKZ,G8MF4&5\C\_[1IW+&S8'6;UL0-KR"&EHI(25=(!(%&;J#. X'.LRYY>A).))F0?SL+B MS,Z4-[>Q/>&X1N;8[>.$!ABAR(])OZM%.DL!I^/0ZG<"-?B)^)]CASHZR1_'W9_0VB<.1AQ"E#P.Z-/7 M2(D9#C&<:&ML O]5]]/7B$-&3MS5RC@?%_? 'O\K&D452G0MAYK$.4(UW""=/\%70$EF M)J/>,CR5O2,@;4 ]_"T;P+]Q"1AC8;UJ:&1T1L9W$E@D14ZDT]);X1;ZQ-#@ M?Z>BX^Y=!^LV>06H=!&X?'(GWWF&PH4)7[T&AG+7[&&+V'?*G;"++A!;?/<: M.">6XO!*+*X+X1#6-&$(M^$?H6!OT 9;J M2OS(:7 [4K%8G\M*5$I&Y8S#IK]'D &S!E2$YD*E(9*?BL-Q? ;%>["Z1O5K M! QQKLW Y&!#B$F0GADIBN1%>R@)\1E&<(K /A(+-FUBNSVX(<[98H<%TI#8 M-G,]86.Y-D9]18J-;"WB-3M@.+Y&;-HW=>(:"P_5+' 7G3[ZG&6SJ46$A,A81N7Z7JV>R:S0^>HHN'XO.PF1K#H :0GA"#]:GQ$MJ7^3*/-PRPWS[#A06&>AH:T$?7//A6 M\S@.X^$G_^_8?*V%/D)];'6ID4.\JQ0!#\04P(*;26.@D^@E[HH]+VC/W;%1 MAYEBO \LVF:.P_K>=T.J.3U.B_0E,C.ZS2R8@CNZJ&/U 2E @\UTJATAK]&' MY+;+TW8^P:A-GV&#@V\C^?_\):>E(Y<9WK^!&<1GIK A5ODHS3<#Y)H?Q3KM M E 5K!:Q)BQHV2JTRLWC>#O_'D+66LA%:@4AS7+INE%M M59E3JC0MT;)O8$):9.X19Z43XN='H"5,'W#GA\<6=.G')I\[Y\W7I MOCINV=GO#@9P[_7.@O@B^4ST;-X5.HYS2O-_Z%J!4C7*M19JE"_KC=9GJM#E MP+('V'"0PP"@/)J3UM'[$.:O4(;QI8U*'$WMTIC]0>-L#:%E2' MM\O91/)/7$?N!_+Y-XC)+ ?M^9\)ACV>V XB3] 36:*9:/LY'FCEYS4T-:>A ME\*1++MN9KBJ*I7+^V3_NF:>=-^LJL&01@-,?1C7T_!X#-03(TR59PB+Y NF M174D9PX0!_N;J[>#VSJ!1ET'LE21&I4BXK.)-\[&CS7E0\])9\J33C;8;I$MMGF9T>/8A7#B=V^KAR9-Q)F43&]A'PO!&\CPQ MA:I\2H;(=6(=71"-LQ2^56,KA='[U='X/];;EF8M7N^51Q@,))\+MPK69 X( MV\@VB+S M9;JIJ!F-5KX];(S/2P@ IL.05#J1D%9[&N^RZJ%&7&@68A9B3H]8Z!Z\8!MV M&D[;<=L2B58P[C2HC/NSZ[=R44-QEEB_3VU^H(NXX"&7">\&6VTT4;EOZFQ, M+)_V66ZC&HO]<3O06S0M1* F>)/9]=4O-:-^!4VSB&U[/\ZI0>0E)LYLEBZT M^V'S^G!CJA>"/)+/.CV7.Q6=,>L %0=4YPN#EJGAP4(&XO"%*2KA4U3UL^(/ MY2;U>)/:XA252+[48T;WD<^I-%5A=](%B-\&RW90F*FG0_,SKKPPXT3XC"M2 MJUR3*B.KMCE[&H(\DK\=//,YHQ/NCX(I6S9!3R_F9E<,FUT)?JU;+38TPN>6 M[J6NTG@H.S?*INW>:EW,"6T038N9#=>:2 M@8^O_Z+F\L#B]-9\/&W7?[#[C:O-#/9(7@;62*L]6G,K_I5'#H^030O<*&I" M$$]&1!TX](D'SN";$/O=O@],%/&9;L^[V6YZX.A(48Y$<#;PB$=6^9(>26M0!=E\MG6[&-;U>-8NED M$_(9Q!?)9])2BU9[UU,[Y]L#>QT\[CY,J4 M 51919:WFA9]C>#]'J[V5A.@2VQQC3FH8)HZX ,6;"M,K, V#N&AF^RSQ*X. M'[%KW$#Y.L@],P$HH(@$Z=CV3P8^RB3=#VR(],;>E]3@D1]TC*6HL64[M1)S MJ4=@62&X1M@T+0:; ^XVVRTN],F.AMRWO%6SF&4B9ZA#M6YMTYM,&D. 6 : M/[NR:7^@.]@@;&#K8V2#&V]WQF*D-X"U@1HWS&4NR$!*=@!P8+V,L=_6 =EE M0V$N>1:.\FCYEPH2Y[>% MM+]RY3KE@*$E\L;.'R>31TGUC M>GJQTBYY A7)>VB ]" >9 9.?7GU#$HJ*4\'G)G37G'&NR:&9X@"CY2)9E!@YB:.R$A":F;* B<@DI9C;\\^0&O^\]-(B7+5YW:TH M@^'[E%7O=):YI%?W9X=7RFV/C3>22E@J/LOIVKP8 :ZH&D#VHA&2DUI4V6OO MKR=4;M\_0ZQ2X6)5M>T!L5X4+L?^5J1G5V:QLIEZD36%:X&ZWT'$$B2:W%/7 M$S&O[WZH5/QA;GK )7#=9F*!X^WS=WOKVSGSP MLB,[3_1'W\28.)F<0NH5MVYDQ+^)=YJSZ:^+OA,N+^V[- MRKA9;6;9C;RQ$R^N,XO'76$T14#9; T_+N$0:G(10A?8>B ..C\O_=D[=M7@ M%9$\ES9&JDBR :0',$N$5[+ CCV; :,V N$ +XICZR*P-T.GQ_TIDV?%L(TT MTJ&&6[#HI@RDE+_)S^4+W)KP!-KCDS\\$FD#OS,5I8XF+W7DB5(.:7<'C$%4 M"0$65FD^@" MJ\JOA"PL:UI<$S%GI<"_MBHJ1-S[R@NH+8(?HFT"^@_TF8+>(+)T""[O3DHX MLBFS9U &%_YON.:KS\)$N%EME2^0$I,4U"@WK\];352OH/IEN5%H5>NUYNX. MOZ9;J=8*M5*U<(Y*]=I)E;?$9FZ__#.WO$B^;J#9>VD'8AN8%LA,;N/Q2S>[ M.Q:Q![HCJH^822PO:\AW*3Z,WX5#[E9V0E3"BSM00A: Y1@JP$YF3LZ+35'% M9,&6B&$;I#SUJ?%-= X].,^NK\H,P]NP*-#1&5@&M7LP!%QSXNZ+W/WMT39U M4#8;D[?LU'[4 O$PE!J31ZHF_*@ZI#_Y4!I8%D_FNA/ MQ.*#7V$RFPBYF/@5&5'IOU:$PCMYL(,=/!3[D^L$0W!WD#UHWP,.[L/P<3K% M;:J[T 4^#.;9I>$ R+?FQ\%UB0':HL_>>]C=T6',@)M=P&H/U)Z'=G.RNPV+Z]G4;$R2 M X93/+UP4:ZU_(N;##[WYN.2OTFZYF6%+9ZK;W('P_4!*9 R65V@];\1YU2)03 M3O@[7T,+3RO$>?WV6@LA[/;*1?8G\^4%EJX8FYTO"5Q36(XQ3*@Q(!H$6NX5Z^Q*BJT3["#W6MJ>]Q#TKBWQ!T8L9GSKOQ]2L0?J$2: M]Y+ !U<\"AOO3W=JO5?'4,H1JIO"'T,S3@BX# MCA!_N26'"A9X(ZK_VB!G4HWQJ)!TP$?YML[JX;68M/OXQ"<(/Q&U\CEO+G[JX4=0!S_C>&-3 M%ZX:U_&K^G#T MBS[_:M2RLGG=.+6:Q_7Z+1(3^/9>/R*/9=[ M#NY?L?;YA1WO]K[=M/#M?Z]ND_V+++.*#S]2B=)MLYW,2,GGK)6./RG%LZOK MT\+S16>/._<4%[?[L*@^=^O=K6M09O;*S]#R=IL8OJ==@3UKY!E>> M"@]8[W7EPVHL6'\.FU7OX^_E3/CT^R5?=,8LG(R3NN9NDV' M-Q*FG>;I^%89_&I+S^9E#0\?K7+]YVGV)-[H9$*1*DG9 M<3_]78"D+-ERXJ:428%HI[5$D=S%[F+W!V"Q./XT/N]_W-\[_M1M=> O8O\< MCWOC?O?C\?OT+_SZ/OOY^&38^0.-QG_TN[^^N0Z#Y BIRCQ!8V]&8S2@=^@R MG)$ IQ^^R^PXU&HA)#'U'8&\'K5&G]=L1 MO_$=>OMO?_+G(OS OOT[XA]1&*%D2E'V2SNA$49)."'W\&.JI@GRX-;KI6:B5#/0Z)3F M=:K$>Z9$&DS@_@YUZ>R*1DA7>:O5PQU5XR6]I<&"QOM[>6-9*^/GFLGE"1\4 M=$=!S+]H3:PT'=QT3/[++ZJ&;3$TW0O\^_V]R8*".T5W!!3N_KGP(J;2 )V3"*YR=AEW_*?88_:W\I[PWDM(<(/1;Q[\ MB:<4/N_O=1<1B3W"GSOW@J_P$YJ&\1SN]6/V[EU6^FD8[>_ENGY.U9C+Y['< M(YH0Z.SS*8EFQ/48E;MIZ-.8^!3-LBX]H;R_K?Z4/4 73 !^VB^SV_?WEATT M-2I=M;!E-#%\PH9A8E5AG^&BHYC8<.S4U"RL.S;6P?H>6=KIBB$_TSAE8^/V M]_Y.ZS@7SS09]15*R;^B/N1;8H+O/,<:,I@0Z) M;J(PYG[Y&H!'RC=3AMH\0"Z[D77D.R^9/GNCY,4J^$5IS2XS<\;P QO9G1( ''&H4S8/10/K;"7:8?-@R4M MERQB:.D5A"3D3L'7+-^?!3(T\[ZQIY9QC0N%(#\$.]O4C%TUI#'KAL\H>TO^ MYP$?9"KC@?\%YLR[N&X=V@<8A'.HP!^N5?9NLWFH'VR*@3_9MOV]O]&XU7;\ MT!6FS5"M0XLUPSYTT@9P@Q7#.0WG- +4&=SL[]%O( M2GWP2= 5(0!IIHD5B$0T#P HALJ@U8"5[@. >':,DJ6G+Z M0L:"V(L3^"US6?!^, T2W7-ETMG<#^\I15V*R!$#?#6A,XC"N";4^1@;96%["4IFX O50 #B"PFT(6N:1J_?S$-'6N. M@_G3(9"*>"^C<9R.-[)>GC[PE!E'L;!M:KMJXW\#TN41.*)S$#'-A;4F8XM! M>FQH.MSEIP:9!4 /'O8BYE[8G3=A.+GS *>O] PP;OY",/9PEK[/L!1LFMJ+ M.LJ+ %S6E+51 ".XB!@/K*@9# :T#KV3 P%.CW=K>#6(#/0/=INP9Q/FW!,F1PC_8,1+FO^.8C80CE<' M.8C<1)3RMG%W![T68A[PP89)V2 W[]U@$1,Z\US>>_S0_3H)[X+X$/UG&K)! M$30D'_T\TSJTTC@'JS"RT\ 5;&@<\SZLR DS&8O6U4D!<]KZ*?;,2.NAX.V9XX%8(":+S/P [W]09T/!4W M7QAI\5JH??0N%=M@6HZVZ54;H/]:Y$V9 0\ T<(&9[.C,F_%'$+\P,.S,99+ MXFGJ@\&E-[%M.-SJ GI#&*I#=V'TE;EWEZ2]F_=?78-QMLY,=U4-RU>INHEU MA;]H?V_C"["E.N # 1>Z*F'WU&A9U./PP6$VH#>^?>-Y633U2+V H :.;*, M*6 E@,S<0;I).K9K#[_T.@W5R;L]"&O9^;,9K&P@R)080S.\:V@W^*4G+NIA M"FI_[W<&ZWP/*.8C5(]!GF7GV/#P7>Z4Y@PW,D0'3+)GDBF!8,$">H844;B( M$/C_B,)H8T*C)73R0X8):#0[1"T8SY HX1;);J?7+#[%S&2 =A0"8V&*:]G$ M&VO\LC>NO!G=$G]!85@#_M&''@M/TV#*_2KG 12>/ 2AJXB]!X2:SNDR P3 M"!*@[C1(9Y7X$(\$Y"8-@?%BSEP3(%,6][D 7#]<3!I7A(N<^C2=0&;D$^;3 M4QRZ'"8"6?:>>1CZC.I-1&:,2=[B;P"^O=40D\+0!8?Z[(8X(5>^!\%IDK'. MW%J21(2-[1GC#\&)ZV!&(-I$[)5@:2 ^QOHB@+">33RE \@X9R#K\3B?+(^) M!W$O@KCHT3OJH5'(9S7;4X]>H^XWZBYXYQ]>@X&!Z-D;+\ =A:]JM_&':U.L[U_#L&>2SI%KBF*E\"F/&EX,V.4. M;-KUP:NQ@3_Z6VLKX?4UC?AHFX )AQ"#(CZC!6;UW%OX((.NO(V/X;C/8"-@ M9JH PF[AV_HD/-AS0-(! ^]$7L"Q&&LVP#8_'6K?,CB<+BS>W=T=+N(K;^8= M0F#;83,>D6O*C#1;+SWY^(E$5V&T=FF4@+R8Z]MA:V[3*"$>@'10:L*BS\2+ MW44\^&MJ=6P]D-/DKA8"E;]@T05#B >_P4"]#^:3<$2TAK8>1F!7GN\E]]S# MNU,>EU-O35B@?8B$F ^%5NYVH?5>D,XU9\:?QJF;D .LD+$6@!O_SG,S"D@Y M74Q=7@>PD86GB'*\PH61,@^QFK)>F(U,XCG$Y0G[EH,5G(&*&1-.#BD>-1F& M ]X(9U0 M8$I"UQ Q0V8(?+(TMX,-+)$@6/"U7!8Z5]YR[;%YJ6P&G3WY.>#JY-TE!DN$ MH>%#G.U^R^;CX?TSC\\E;I=L1!8D(*NCXY-+8+,3D1O =V?,IGK! M+> 1#HHN %0%K%_U^^WTQC'UC]#_5=]:AO6N82MJ0[,5/?VI.P.)'Z7^A869 M_YG<>'.?>=+'$OE7HX%./>I/CH#"#?T C/ZYH&"^P"!J-++-.[\MZ-DDC M">='R)HOLUP:5V&2A+/LVA6;E(F6UTY\XGY%J;3CT/AEJ3A%Q V7,K12<(3, M<-!@W+TN.4D-O M#P>C8;_7:8V['732ZK<&[2X:?>IVQZ--L73<.NEW4;O;[X\N6NW>X.S7-\H; M_OVBU>GDWQ_)#631AO8#QG]6;G?>))FR)BD'2]MW0]\G\QA:FG]ZPVWK>'R9 MV]BXLSTK&'=>FPH$(B;6P:]OM*4,MVX\^91%RI>NKFG]]64@);UE&<#_+NO7 MC1Z%TZLTG.;!]!5\-)O JFW7JH+TE2IUMYQ8%O::UD'1,(OJ:D=?IJ MH>2_9QS5H.L=F%U_W SP@5V)[;IO)* M5B2I2(T]T\N7. MPU4W$%CS8X#F,H+DW5V\UA6T_L%D*W[LW3Z4S)Q,VZYO. M_2B'39/-6>07N;B>7O;I-5QML@F10J? 23P5PRI_*<\@E\D/8DA2>'UE&295 M]2"_3[V$5MMMM%R7Y;;&*8\1=:EWRQ:@,,NE$L,^RXYR3:RP#4F&)KPX!5*: MA2W;8LG(5?4MNX5.6I-;EJ*5N9DDY&E6OD>C6)IK$?1UK%HZMG5+>'$*I#0- M6XZ.=G (IK9Q#%-RG0Y+TMX>N6T@[^3?24"?)QB6OX! D2_\FLVV*RPQ5L6HZK 9?+<0JF/),K-H&-FR[_.3>GT)9 M(BE=(-,JO94B41%:8S\'.8KU@H/AH"'S<<6R*R&I"*TQ$6=<.O2:LMIQ6<8+ M^5;^#(M ELHJHIHR37>75*8Z.M94N6KT3U:-6+F7Y#Y;A&;ES]**):QKN7W0(N9]EI$Q4P M%YG8D//'SF"SL*8V:^,JI.X?-E,Z_!C'RFZFW,&\EB ,&C*W96OI$>P82Z(WX(1_>WS[WQ'\?O/W^L M59@4TL2$I"*TQJH$"U:*:*\X">D5A&FE2%2$UI@PV2FC:1@E#790<9:>$I) MD%24,NLSXZ;C8-V15>-V0U\."]V:S)\MI)7]D/&Q[E%XC4IVI*@7H#"@Z)Z2 M2 RK+3L"ZI:#55O\[!*15 8]N8S]%<* EG88W-(H>4C1GTP:BG"BU,@I;'JVC8VC!+"@HB(9OVPD#FY3T\*22(RH=)@BZ#? MQ+KN@*>17F:'E&9BV]2P8I:@-&&@S/H!(;R*O[N(DW FCP@I;"[&,72LE#&Z M%Y+*ZRC-,;!BRR*XQ?B81V>%)*$\*60[]>$5K-DE%#$5DLJKJ$S3+&RJ)4S3 M"P-@QN0;71\82:V+18"H11Y4V)6]R25+JF!;*GTELI$A6A-5:Q34?' MG]<.#%G;>R1W)0K42I&H"*TQL2=?@C! Y4_ "&2F!E8M%3=M615WAY0& T?# ME!F\Q;B937N2&JO%)"M@37*^;YE9"D:E*"4L:DC-EZSYIJ9@QZFLU]OQ@KG5 MF>.5EK]!:P:V' MT914$A;$I**T!H3<:&J'A^Q6C7Y1#15'95FUT2_P%_8 T M1<%*^A^*IR1B6Z,6R32,X$6 ^VQL*AK6-(UOF-*P92IL7T]^JQ?'; ,5^RU< M)'$"'Z!!B,3L/-H.=>GLBD9(5W'*A:9H:OHB15,P@C?,J9MXM]2_1_]'=J B MZ'.%"2]*@12FI8>L5=/A[4#63PO>GGAAD*]1S8DW:7@!%%Q4+-T M;)>1I28D%=&5)@Z <=W%;,%K:*5L3NBUYWHR7;D0^F^-)G9@?.MH6T]8?B\TMPY;WHF.6)[XEI"5PD%N.)M'=$J#V+NER O@>YFEMN2*Z&/^ M5&PI*K:;X@^WI.Z?ZEY1=*P[)D- H(.ED$3JG$\^%O[W M/?QW%/^Y"#_$B/ZY\))[N0!7H!;8B0^.C@U=UJS80>59N*DJV#!+4IY,RQ'3 MM$IOI4A4A-98Z6DYO%H%O.QRV._W!F>H-QAW+[NC\:@"&I>@>0F:#:V\3W!7 )?'*&4;O;[X\N6NW>X.S7 M-\H;_OVBU>GDWQ^U!?AK@SZO(N_9MMQYDV3*2"L''U!F)! N?#*/@:/\TYL\ MN#PUK.P%ROS;0T3X^]$CO[IJ@O]=Q(EW??_*(XBL/9I11(.*Y'WS;IQ_'KA? M2?27-(G"A\U%RWS=A)]4F1U<>BNO8 $+C0*<5G.@,/XL??8#5$\YOI?C08Z]:@_.4(7 MY 8"U @P'PU<>$!C7UR6-W"$SHD7?$##.?L6'S%ZV4\?T!>VHP[N1HU&WF4Z MO2\YLVD+TRYCL>9E%_(@R:\]"IPGZ8P"EU\^P?'@FU=]\6-?O1Z(G_K81[[X MJ70>H#WT"Z8O/U<%M&!=-ZQGLR<>>S5=/WAP@JS;/+W#.'A&S2O:R/7P 8WO MY\!@*P)H[GY S*CJ:X&(1.YMOK0^_PI]LMSU/6#C3!DE676T_->?OP>U+E! MLU<1)5\;5Q1<"3 TY\;S FU#*R_6C8.;_P/]BW6*JZUCK4[-;&?ZVV:DL1N\ M YQD&43[>WSQ;] :]X:#5A^==SN]=JN/46_0/D2M00?UQB,T^GPRZG5ZK4M6 M;NB$!8KV<# :]GN=UKC+;!#^G'<'<.?P% TONI?\=2/^?'MX?G'9_=0=C'I? MNNBLU1N\[P]'ZU6+JHK1A!I;M8=,K(-?WUB/?>F+9GNW8H*G87:()43EU+#8 MES\HB6+4#29T\G QWWJ=-E&OP/RPZ':B5<=.-+X<6H<9D(I*?U>3Y1[AHZ9U M4+!L+KM?NH//WZG"]X@#M5 &7CX>+XNNLQF0%KA?KXF59E86N+IBJ!O=K:M= MU;!M&-AYIC+(*XM!+AO+14A)I78:JU(N/V"1]G T9B/P'V(2 43_N@;&#ANR M=6PHAO#R%$AK;)N/HF'%W@P-*^ :)"+8"4,JO94B41%:8Q5#!&>7P]$(75P. M3WOC*F=ZU3+=V<"F8V'=*6&CA]1]R;H'/&EHV%9WILJ42.8HXYRD4CN-50R9 M9%D"@S/4_=^+[F#4'1W)Z0IA6BD2%:$U]G-@(+^S0F7A1L2G<Q:BL0$&09_AU26M,&M>DES%A78#==X?[EC 8TRK?2,0]#)C,O M\.(D(BPAOP*V) ?7.7\.JP^/%:>$&O%2]R7KWF2U [!C5=;M;7%BA6_V1>&< M,I\4W"#Z;4Z#N-1J_M) GRQ*:KC)BJ$:)2Q*2N67K'R+(1V(3'95O9.L.[EK M*+_T5HI$16B-E8Y/CD\^LJU?Z/1R>+ZR34PN3%%Y%[W-%K?? MR;5M85HI$A6A-28BKN '_M X27DL_9@S@:Q4AS&/^)FX(BFLC,U8PN3+K#N2 M;*5(&F8QPVA3Q8IEB3QY(I*Z; ,[JCR8]9\VL/O-G9+@AJ8\WA OD,?(%T)? M _NTQ#\'2""-F483JZJ$)_\ GLSFQ(M8+=:42S^,8U:]]28,)W>>[TL[+23T M:1:O+Z\V7W?&7VKL9^DWJNI3=@NK#-F9\549^LB%R*Z1U& 4VDA5;)0@$O-1T3&]KKFJE4?-FE.BP%FV7L M?I-9NV+B^-);*1(5H356.D3)LW9/NJ?#RVZ>V3)N_:\L,%GHB(?5,L9Z<^L3 MO7(FIB"-8;;.U]2<"HY8)"#8-7,JO94B41%:8U4 !!>7PR^]46\X0( )J@0) MY-#U,7^J@W6KA/VF4O%ESUD I-25K6"R0H?'I"PU&P]NO:B*G+XJ:OFC:%E;TUU68Q 9BFE/I MK12)BM :JP(VZ/1&&2#H=B0>$,BXA*0BM,9$S"[M\42N]V]9TOJ[E-'K*)SE ME1G#@*>R3[S8A2>]8$$G*S]5P-#D'%J)Z=92YV5/F&-'L;&J*E5UAO)H'AE1 MZT9%:(U5:5)D9>94#H?D]&AM-:9BN]D$I55Q>G0']N_V:1P?I0P&-,FWMI D MB;RK14*N?(J2$ 5AT&!CH"CT?5:PWLN*DE3 NB0>SOFS(.2HXE=&DHI_,A!2 M':R:-2]5O[J2W!J/+WLGG\>MDWX7C8?HI'?>0[W!.)L_;O71>;?3:[?Z*2.] M0?NPRNEPVJ$&7A]-P@6XXR(-YY=_R,OV=Q=CQS:Q8PI=HDGJ_ID]QDX3*W;- M]AF7'EX%&AN4WDJ1J BML8H!F;0T=7MX?G'9_=0=C'I?NG*B1PA#$Y**T!H3 M9J;G-(PHJ"9ET5U$$0W<>Y1$)(A]OJ*-R.2_BSAAM=PJ8$QR>)_S9SHV-IIR M9U#]-/_6,5BII=?=:5XE+%2Z3]J&G)MUSP!D6E. M\S6R>"KKQ&JK>\!VBH:;EJQ2)X<* K12)"I":ZQT,/-[MW?V:=SMH-:7[F7K MK(L&G\]/NI=H>,JF?\Z' S3ZU+ID!>NDF0G02I&H"*TQ$:=]3DCLN2F#))B@ MB>=XU+ *0V+3JNQY'C(16(;0 MNE$16F-5F@_)S_.X@,$0'P+)M6]A6BD2%:$U)DSZ;SOD):R 0LKELI!5@P^* M:CT>JOK:@'5HRA6AVFE=/7SE,Z9$G/'IK!3ODXYOQ[I S:OZU57MRJ&]]55P M@9&>G.3>!2.7H*Z66@??MO6=?,^ NO<\.1 ^'U^LDH&G5.:"4"ORB(_1)^K? MTL1S"1 @0=S(J,Q(=..!2( "4I"J,4>V*BJ7LJ3H+0[Y+X!SX/U?C08Z]:@_ M.4(7Y ;T-:)_+FC@PF,Z^^(R:'>$SHD7?$!?B+^ 'S34:.22[O2^Y-RE34I= MML7:DUW(S8-?>V0R)VEV*Q=8GFR;)EVVN_W^1:O3Z0W.?GVCO.'?1Q>M=OY] MW00AG/AD'@-S^:N5@TW3@0UBZI1%3D)_+'EJPK@P66=@32\// M7JWK!P]R9<;Q] [CX!F]K@@^%_D'-+Z? X.MB%QY[@LP H;FW$Y>H&UHY<6Z M<7![?Z!_L4YQM76LU:F9[7@'VPW>CT\^LA3G_;VU'.<\O1GS_&;4&G10;SQ" MH\\GHUZGU[KL=4?')\P=MH>#T;#?Z[18XM%H#'_.NP.XDR4=M4:?T&E_^/OZ M7K-,.@]]?;5O/^[[CR0(4FF#)*XB[UD)KO7]9WW$FQR@"CH::@^96 >_OK$> M^\L7[2[8BIF=AE'*8#*EW").EM(_^?@')5&,NL&$ >Q'OW6H2V=7-$H;K*NX MG/6;U7&-Z&:C5<=L-$53Z[%@5U'I*U7J;H]P3M,Z*+C!#U$K/4_H68D\8D\ME+L7C!%+INML1IUU$D'=Z-9(Y2(NZPQHDK+']FN+ M$6*_/W,ECSV0RLJ55>$#87=@>:2UK'(79^.Z$$74#0/7\RD_!('7@("K+HFG M:!'3"?*"?-DXN$'$3;Q;+_%H?"2&,=UFW)+(P2[R]^55IM$?0UP\"JNO4",:4+4R"5F0!TC!+.M"D+[6S!N_1F M<^)%#.\\C)C8L;9G83BY\WQ?&FHAOL7"JF9CM2G^ 4P"::V$!$,Q(4PON 4' M$T8P*$H9]99>!P97,8UNJ;38(N@[.K9M0WA9BJ0QK#DE*$P@!-/R_?".!"Y- MV;P.(YZLEUPO?$1<%]I3:B5.@6SUK:ECRWG=!$6IK9^EKQH6=K:_1Z@N&*:U M,N&2;16Z1A.V?P@<#/OLA@'/O&15@>=1.//B.(SN41 F5/J?8H;[)JN 64*Y M#R&IO,[ %RN.6DZ=GI^#.")I6" [*KV5(E$16F/_&'T4655A2H(;^FA].(YI M$O,U'-\C5Y[/UXJES0G12I&H"*TQD>8_LCF.E,N(NM2[94>32 ,M@KYEF]C0 MY*KP#JGLK<$/AS>-LK;2"C7M,;EEA4/XM@)N+*R%BQ-LBB39'60=>E#=D-AFF)BTU:J.NC9-81R M$=$YN5_)V&=3*V$RI='*8$CZFH*R%6Q58Z>0"2].@90& 4)AV[>473@'L9(N M9IC/WF8YLI3$-&6"+?PN8IK-ZDI[+<1>G::%]>;K'F,LU?5/LH(,K8K;#7<- MR:S/Y *H8<@%HR0B$SF;6]1LBXZ;NDQAVPUU&6P2%UO;KX0I]@+1VA3N=13. MD+N(DW F)W&+2K4$<,U.YY6I:3ND-!@6J7P#X=9G8FH 73:-D&1^2^'3+ZJ) M%47N[]DAE1DF-K7*SO7N!'X9DV]T?4PD3;.8P9!C8L=^W5-DI+I^VI-H#CC_ M$C*1!$4L;(5HS:ND2;G$=:,%E\)!Z M+UOO!M8M%:MJ[1:ZMNT5YU%XZTW ,U[=?\MV"4L-XL"RXY._@BM%HB*TQGX.%!7KEAZ?[M0;?.F.7GRZDP!*J(>I"4E%:(U5 M8/:F\ -2VC!>2OE+=U?!P(E/T!#WSX47>VQ6AM-KAS8Q&TG2+H*]CQ3*Q:LOCX'9( M:6]?36N5J*-3/+I91.Z4Q-DY3>!1YA'+MTGN,9K[)$@P1S04G,Z8*?%]S26&Z]V,F,K[>68[&$+Y%= MF=3Z$ZVK&C8T QNOO&]0G&SGY[=;/.\-Y78+.2JOLQS*BCLI6%$JNYB_ M:SOO'^^^2-O]-H-H[]*OFUR3S,&O6&QF.?A+4";W8=36!IHY/JOR+@QYTN=. MQ-O26RD2%:$U5J7-5QMV89SV!JU!6^["$,SJA*0BM,;$64"+0I?2R6HAYW@: M1DDCH=$,^:', I+S,U6B\BK*LDRL*Y6MAK%;:4 ;'(P?,M:D?RET2M%4L>-L M?3FC=&$*I#)3ASZLU.@'&\8*=3L'P@-PQN:91X5SYE M=\W@MS"Z1T&8R+U=!05+;):UEB$DE5=*%F5G1.O;KSA9#Y!SF1\7NLQ#?#2( MDKZFH'19'6O-U\W-E]KZ^<1#U<+&]D\PJD2.3>$^I35C!_=EPR8O8( FVZ[^ M-@G?H8CZ)($KO*%6:S1M+%J2P>S&^I2#9LETM02P[QF3E_J?F2&\R[F M4EA8-11LZB6S8#E:LRA[PL]NISL^[19GJ+)?2*D]%5&55 )R] M0H;S#S==R*S6BD5CT. *&*M1SI8T@1436,%D99B S&L6*+B6WDJ1J BML2KE M-7=/3[OM,1J>HN[_MC^U!F===-D:=]%P@%B^871%;[P@ MX"OAUV@.SX>3"IB#!+3+9!&=[>J1R^ UU#RVJKO-XG7WDF]V7328K#JMZJX; M:8>:"48S"1=7/BTXL/WR;,-?SM+VEP\,W'2:,#"7*TC2&!Y"6BVQ6.G6*1"P M+[V5(E$16F-50C6CSQ<7_>XY@)A6'RUKY:#>X'1X>=X:]X:#(VEL0K12)"I" M:TR8[5]GE8ZQDLI75&QL_VP3.354MM4+.9(0DHK0&JO2U-!@.&CP&:'Q96LP8M62 MAX,1RSGN#;YT1V->0GG0V5A061JA$*T4B8K0&A-FRJB7U1U,>>1%P @,BM*# MCF>S,$!Q$@(&S ]#9L>2)O=/SD1FQZ__R?*(SN!M?Y$ C:D[#4 *-_?PGD., M^LGDL +&*+'V:KH\ME6[%E40I?HWS4%A4V_6]D"O4CWI9B_Z'^9%X:D _"D) MIPOT*8SY=)7L.=7J.3HV['J4CY7JW\!>9>N#"(8W-WO)LT5X#TX1L*9TC]7L M'X K->D>:ZO^RKK'NN')P1-,_]9V>*7 M=>U!)G9T!5MJS3?^U%7]E76@M<"7_YDNP@F1?:):?4+%A@-16V+*+:F_$(;J MZA?%!9;9$3'L-V_&JG=2]C5&20B7KCVWU$,70OE2S?[*8\1=<.;@"<+\Q+I.)E9- ^N.W'=12_57UC<*"AKEVLR.=A1V#D(3FYINVY1<9]H84>% M2*QN_13YFGI%J?XZ8<7A(HD3&!L#B93-?%%:YO#L5K\PL*W(O/#:JK^R0^<= M@(@_X0,E0I1]0:J]6FK7L6*96+5W\62'"GK%-%TQY3#-64Q"=$61%\<+&#XO MYN )W3"XI5&<.<7T6^*!JMEAY#.X,XSN41 F,I.Q:IW%Q(:$B_55?ZEP\?VX M==+OPN?CBU5:\*C*G!AJ11[Q,?I$_5N:>"X!*B2(&QFI&8EN/) )D$$*4K5B MO=XCOB^ 2^#S7XT&.O6H/SE"%^0&E#,"6$@#%QXSV!>7X<(C=$Z\X /Z0OP% M_*"A1B,7;:?W)>CL2%DQ_6Q&6(VMU^_Z+5 MZ?0&9[^^4=[P[Z.+5CO_OFYO$(=\,H^!N?S3!W3G39(I:[URL$$<*_&,NW:7 M^+E-0@O6C93%(?;$TLJS5^OZP8-OP=U_IQF MH447Z[=S.WZ@=;'^]M66L!:F)K5#'><)G_/DO:HT#U ;9'T5>3]F%OZU7X/3 M]R?#SA_,)[W_-#[O?_S_4$L! A0#% @ #D225&SQ"24Z P [PL !$ M ( ! &)I;6DM,C R,C T,3@N>'-D4$L! A0#% @ M#D225#QB>.[_"@ ;(< !4 ( !:0, &)I;6DM,C R,C T M,3A?;&%B+GAM;%!+ 0(4 Q0 ( Y$DE0;M@654@< +U8 5 M " 9L. !B:6UI+3(P,C(P-#$X7W!R92YX;6Q02P$"% ,4 " . M1))4SU#\C4$2 #E80 % @ $@%@ 96$Q-3@U,#8M.&M? M8FEM:2YH=&U02P$"% ,4 " .1))4%#?/B9HJ "#20, %@ M @ &3* 96$Q-3@U,#9E>#DY,5]B:6UI+FAT;5!+!08 !0 % $L! ( !A4P ! end